|
Volumn 61, Issue 5, 2002, Pages 414-421
|
Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
HYDROXYCHLOROQUINE;
IMMUNOGLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
ADOLESCENT;
ADULT;
AGED;
ANTIPHOSPHOLIPID SYNDROME;
ARTICLE;
BLOOD CLOTTING DISORDER;
CARDIOVASCULAR DISEASE;
CRITICAL ILLNESS;
DEMOGRAPHY;
DISEASE SEVERITY;
FEMALE;
HOSPITAL ADMISSION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTENSIVE CARE UNIT;
KAPLAN MEIER METHOD;
KIDNEY DISEASE;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MALE;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
REGRESSION ANALYSIS;
SURVIVAL;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ADOLESCENT;
ADULT;
AGE FACTORS;
AGE OF ONSET;
AGED;
ANTIPHOSPHOLIPID SYNDROME;
CHILD;
CRITICAL ILLNESS;
CYCLOPHOSPHAMIDE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTENSIVE CARE;
KIDNEY DISEASES;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
MALE;
MIDDLE AGED;
PREDNISOLONE;
PROPORTIONAL HAZARDS MODELS;
REGRESSION ANALYSIS;
SURVIVAL RATE;
|
EID: 0036252076
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.61.5.414 Document Type: Article |
Times cited : (50)
|
References (19)
|